iShares Biotechnology ETF
824 hedge funds and large institutions have $4.56B invested in iShares Biotechnology ETF in 2022 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 228 increasing their positions, 300 reducing their positions, and 73 closing their positions.
Holders
824
Holders Change
-29
Holders Change %
-3.4%
% of All Funds
14.25%
Holding in Top 10
14
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-6.67%
% of All Funds
0.24%
New
56
Increased
228
Reduced
300
Closed
73
Calls
$257M
Puts
$721M
Net Calls
-$464M
Net Calls Change
-$386M
Top Buyers
Top Sellers
| 1 |
MPCL
1
My Personal CFO LLC
Vancouver,
Washington
|
$787K |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$1.18B |
| 3 |
3
Citigroup
New York
|
$183M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$180M |
| 5 |
E
5
Ergoteles
New York
|
$1.48M |